Adherence to the ARB/CCB fixed dose combination tablets and ARB/CCB concomitant therapy, a randomized parallel trial on efficacy and safety
Not Applicable
- Conditions
- hypertension
- Registration Number
- JPRN-UMIN000006412
- Lead Sponsor
- Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 440
Inclusion Criteria
Not provided
Exclusion Criteria
(a) ARB, CCB administration of drugs contraindicated in patients with hypertension and other symptoms (irritability, and pregnant women) (b) Patients deemed unsuitable for the doctor to conduct a study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method